Leading science, pioneering therapies

CRM Publications

Found 5 results
Filters: Keyword is Encephalomyelitis, Autoimmune, Experimental  [Clear All Filters]
2013
Stoffels JMJ, de Jonge JC, Stancic M, Nomden A, van Strien ME, Ma D, Sisková Z, Maier O, ffrench-Constant C, Franklin RJM et al..  2013.  Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.Brain. 136(Pt 1):116-31.
2012
Hampton DW, Innes N, Merkler D, Zhao C, Franklin RJM, Chandran S.  2012.  Focal immune-mediated white matter demyelination reveals an age-associated increase in axonal vulnerability and decreased remyelination efficiency.Am J Pathol. 180(5):1897-905.
2010
Vesterinen HM, Sena ES, ffrench-Constant C, Williams AC, Chandran S, Macleod MR.  2010.  Improving the translational hit of experimental treatments in multiple sclerosis.Mult Scler. 16(9):1044-55.
2008
Anderson JM, Hampton DW, Patani R, Pryce G, Crowther RA, Reynolds R, ffrench-Constant C, Giovannoni G, Compston DAS, Baker D et al..  2008.  Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis.Brain. 131(Pt 7):1736-48.
2006
Gregersen JW, Kranc KR, Ke X, Svendsen P, Madsen LS, Thomsen ARandrup, Cardon LR, Bell JI, Fugger L.  2006.  Functional epistasis on a common MHC haplotype associated with multiple sclerosis.Nature. 443(7111):574-7.